MedPath

Effect of Periodontal Therapy in association with Probiotic in the microbial communities of the mouth and intestine.

Phase 2
Recruiting
Conditions
Chronic Periodontitis, Periodontitis
C07.465.714.533.324
C07.465.714.533
Registration Number
RBR-2vjvxv
Lead Sponsor
Faculdade de Odontologia da Universidade Federal do Rio de Janeiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Subjects with eighteen years or more; who have at least fourteen natural teeth, excluding third molars; and advanced chronic periodontitis which is determined as pocket probing depth equal or greater than six mm in three or more periodontal sites and bleeding on probing in twenty percent of the sites examined.

Exclusion Criteria

Exclusion criteria are the need for antibiotic prophylaxis; having received antibiotics therapy in the three-month period prior to the study; having received periodontal therapy in the six-month period prior to the study; chronic gastrointestinal diseases or abnormalities of the gastrointestinal tract; metabolic disorders; cardiovascular diseases; immunological disorders; HIV infection; be a smoker or have stopped smoking in less than
five years; ongoing orthodontic treatment; have Body Mass Index equal or greater than twenty-five; be pregnant or breastfeeding, if woman.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in intestinal alpha diversity after nonsurgical periodontal treatment, measured by feces microbiological profile showing 0.6% increase in alpha diversity.<br>Data collected previously to periodontal therapy and 2, 6 and 12 months after finishing periodontal therapy. <br>
Secondary Outcome Measures
NameTimeMethod
Increase in intestinal alpha diversity after nonsurgical periodontal treatment and probiotic use, measured by feces microbiological profile showing increase in alpha diversity higher than 0.6%.; Difference at mean pocket probing depth between the group that use probiotic and the group that used placebo. Data viewed by mean pocket probing depth in probiotic group being 1 mm lower than placebo group.
© Copyright 2025. All Rights Reserved by MedPath